1-20 of 27 results for subject:Haematology
Librarians' tools
- Search time
- 0.391 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Haematology
- We searched for
- subject_t:Haematology OR subject_ses:10587
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people diagnosed with leukaemia have adequate access to haematology specialists.
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people diagnosed with leukaemia have adequate access to haematology specialists.
The National Cancer Plan for England, released on 4 February 2026, sets out a commitment to diagnose cancers earlier and ensure people receive timely, effective treatment.
The Government is committed to helping the NHS England detect cancers, including blood cancers, earlier and provide faster treatment to improve outcomes.
NHS England uses non‑specific symptom pathways for people presenting with symptoms such as unexplained weight loss, fatigue or general illness that do not point to a particular cancer type. These pathways are especially important for detecting blood cancers, which often present with vague or non‑specific symptoms.
In addition to ongoing investment in diagnostic capacity, including new magnetic resonance imaging (MRI) and computed tomography (CT) scanners, we will support NHS England to diagnose all cancers, including blood cancers, earlier and ensure patients can begin treatment as quickly as possible.
The Department will work to end the postcode lottery to ensure that access to the best cancer diagnosis, treatment and care is available for everyone, including leukaemia patients.
The Department is working with partners such as the Royal College of Pathologists, Cancer Alliances, and genomics programme leads to strengthen diagnostic workforce capacity across cancer services, including pathology and cancer genomics. This includes investment in new training pathways, digital pathology, and genomics education, all of which support timely and accurate diagnosis for people with blood cancers, including leukemia.
NHS England is investing in expanding specialty training posts in high-demand disciplines, including haematology, and is supporting local systems to retain and develop multidisciplinary teams. This includes increasing medical training posts in haematology and enhancing the scientific workforce supply through initiatives such as the Scientist Training Programme and Higher Specialist Scientist Training.
As of February 2026, there are 2,318 full-time equivalent (FTE) doctors working in the specialty of Haematology in National Health Service trusts and other core organisations in England. This is 130, or 6%, more than a year ago. This also includes 1,082 FTE consultants, which is 51, or 4.9%, more than a year ago.
We will publish a 10 Year Workforce Plan later this spring to put the NHS workforce on a sustainable footing so staff can deliver the transformed service set out in the 10-Year Health Plan.
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve timely access to haematology specialists for patients with (a) suspected and (b) diagnosed leukaemia.
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve timely access to haematology specialists for patients with (a) suspected and (b) diagnosed leukaemia.
The National Cancer Plan for England, released on 4 February 2026, sets out a commitment to diagnose cancers earlier and ensure people receive timely, effective treatment.
The Government is committed to helping the NHS England detect cancers, including blood cancers, earlier and provide faster treatment to improve outcomes.
NHS England uses non‑specific symptom pathways for people presenting with symptoms such as unexplained weight loss, fatigue or general illness that do not point to a particular cancer type. These pathways are especially important for detecting blood cancers, which often present with vague or non‑specific symptoms.
In addition to ongoing investment in diagnostic capacity, including new magnetic resonance imaging (MRI) and computed tomography (CT) scanners, we will support NHS England to diagnose all cancers, including blood cancers, earlier and ensure patients can begin treatment as quickly as possible.
The Department will work to end the postcode lottery to ensure that access to the best cancer diagnosis, treatment and care is available for everyone, including leukaemia patients.
The Department is working with partners such as the Royal College of Pathologists, Cancer Alliances, and genomics programme leads to strengthen diagnostic workforce capacity across cancer services, including pathology and cancer genomics. This includes investment in new training pathways, digital pathology, and genomics education, all of which support timely and accurate diagnosis for people with blood cancers, including leukemia.
NHS England is investing in expanding specialty training posts in high-demand disciplines, including haematology, and is supporting local systems to retain and develop multidisciplinary teams. This includes increasing medical training posts in haematology and enhancing the scientific workforce supply through initiatives such as the Scientist Training Programme and Higher Specialist Scientist Training.
As of February 2026, there are 2,318 full-time equivalent (FTE) doctors working in the specialty of Haematology in National Health Service trusts and other core organisations in England. This is 130, or 6%, more than a year ago. This also includes 1,082 FTE consultants, which is 51, or 4.9%, more than a year ago.
We will publish a 10 Year Workforce Plan later this spring to put the NHS workforce on a sustainable footing so staff can deliver the transformed service set out in the 10-Year Health Plan.
Last week I hosted a haematology workforce roundtable to understand the significant issues in that vital part of the NHS. It is understaffed, overworked, hampered by inefficiencies, and 55% of haematology consultants will reach retirement age by the end of this decade. Will the Leader of the House seek assurances...
Last week I hosted a haematology workforce roundtable to understand the significant issues in that vital part of the NHS. It is understaffed, overworked, hampered by inefficiencies, and 55% of haematology consultants will reach retirement age by the end of this decade. Will the Leader of the House seek assurances...
Absolutely, and I assure the hon. Member that the Government’s national cancer plan will consider workforce issues, particularly in relation those who are specialists in haematology and other areas of cancer treatment. I will ensure that health Ministers and the Secretary of State are forthcoming to the House in developing...
Absolutely, and I assure the hon. Member that the Government’s national cancer plan will consider workforce issues, particularly in relation those who are specialists in haematology and other areas of cancer treatment. I will ensure that health Ministers and the Secretary of State are forthcoming to the House in developing...
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of haematological workforce shortages on patient (a) outcome and (b) experience in (i) Coventry North East constituency, (ii) Coventry, (iii) the West Midlands and (iv) England.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of haematological workforce shortages on patient (a) outcome and (b) experience in (i) Coventry North East constituency, (ii) Coventry, (iii) the West Midlands and (iv) England.
The Department has not made a specific assessment. However, local assessments will have been made by the bodies responsible for the commissioning of services.
To ask Her Majesty's Government whether any members of the Joint Committee on Vaccination and Immunisation have a specialism in haematology.
To ask Her Majesty's Government whether any members of the Joint Committee on Vaccination and Immunisation have a specialism in haematology.
The Joint Committee on Vaccination and Immunisation (JCVI) secretariat is provided by Public Health England (PHE), as set out in the JCVI Code of Practice agreed by the Department. In 2013 the Secretariat was transferred to PHE from the Department as part of the Health and Social Care Act 2012. Membership is determined on merit and in accordance with the principles of the Code of Practice for Scientific Advisory Committees and the Code of Practice issued by the Commissioner for Public Appointments. The Chair and members are appointed based on their suitability for the role through fair and open competition and assessed against specified criteria. The Deputy Chief Medical Officer Professor Jonathan Van Tam is a medical adviser to the JCVI but is not a member of the Committee.
The JCVI has no budget. Members are not remunerated. However, they are eligible to claim expenses in accordance with PHE’s rules for travel, subsistence and overnight accommodation. The JCVI’s members will not gain financial benefit from their membership. The JCVI cannot commission research but does identify gaps where additional research would be helpful in informing their decision making.
The JCVI’s members have a wide range of specialisms, including vaccinology, immunology, paediatrics, adult medicine, respiratory medicine, geriatric medicine, infectious diseases, epidemiology, virology, public health, mathematical modelling, health economics, general practice and health care associated infections. The United Kingdom health departments agreed to take advice from the JCVI on vaccinations and immunisations as the expert body. The JCVI does not have a haematologist member.
The JCVI’s COVID-19 sub-committee may, in the course of its work, invite experts in certain specialisms not represented in the membership to attend and contribute to meetings, including experts in haematology. The JCVI works closely with the Medicines and Healthcare products Regulatory Agency and the Commission on Human Medicines, who have an expert working group that includes invited experts in haematology.
To ask the Secretary of State for Health and Social Care, how many haematological Clinical Nurse Specialists there are in Enfield Southgate constituency in the most recent period for which figures are available.
To ask the Secretary of State for Health and Social Care, how many haematological Clinical Nurse Specialists there are in Enfield Southgate constituency in the most recent period for which figures are available.
The Department does not hold the information requested.
Letter dated 25/02/2015 from Alan Foster, Chief Executive, North Tees and Hartlepool NHS Foundation Trust, to Iain Wright MP regarding the management structure for chemotherapy and haematology nurses in the Trust. 1p.
Letter dated 25/02/2015 from Alan Foster, Chief Executive, North Tees and Hartlepool NHS Foundation Trust, to Iain Wright MP regarding the management structure for chemotherapy and haematology nurses in the Trust. 1p.
Letter dated 27/10/2014 from Alan Foster, Chief Executive, North Tees and Hartlepool NHS Foundation Trust, to Iain Wright MP regarding the haematology department at North Tees and Hartlepool NHS Foundation Trust. [redacted]. 1p.
Letter dated 27/10/2014 from Alan Foster, Chief Executive, North Tees and Hartlepool NHS Foundation Trust, to Iain Wright MP regarding the haematology department at North Tees and Hartlepool NHS Foundation Trust. [redacted]. 1p.
To ask the Secretary of State for Health, what recent assessment he has made of the level of demand for haematology services in (a) England and (b) the North East of England; and what steps he is taking to ensure that resources are able to meet demand.
To ask the Secretary of State for Health, what recent assessment he has made of the level of demand for haematology services in (a) England and (b) the North East of England; and what steps he is taking to ensure that resources are able to meet demand.
Since 1 April, NHS England has been responsible for securing high quality outcomes for patients with haematological conditions. It has published a number of service specifications for specialised haematological conditions, both for adults and children, which set out what providers should have in place to deliver evidence-based, safe and effective services. These specifications aim to ensure equity of access to a nationally consistent, high quality service for patients.
Clinical commissioning groups are responsible for provision of non-specialist haematology services locally. Local commissioners work closely with providers to consider the most appropriate clinical model for the delivery of haematology services.
To ask the Secretary of State for Health, what estimate he has made of the number of vacant and unfilled posts for haematology specialists working in (a) England and (b) the North East.
To ask the Secretary of State for Health, what estimate he has made of the number of vacant and unfilled posts for haematology specialists working in (a) England and (b) the North East.
The number of vacant and unfilled posts for haematology specialists working in England and the North East is not collected by the Department.
To ask the Secretary of State for Health, what estimate he has made of the number of haematology specialists working in (a) England and (b) the North East; and how that number has changed since 2010.
To ask the Secretary of State for Health, what estimate he has made of the number of haematology specialists working in (a) England and (b) the North East; and how that number has changed since 2010.
The most recent National Health Service annual workforce census was published by the Health and Social Care Information Centre (HSCIC) in March 2014 and shows that in September 2013 there were 1,507 doctors with a specialty of haematology working in England; this represents a 13% increase since September 2010.
The number of full-time equivalent doctors with a specialty of haematology working in the NHS in England and the North East as at 30 September in 2010 and 2013 is shown in the attached table.
The next NHS annual workforce census reflecting the position as at 30 September 2014 will be published by the HSCIC in March 2015.
To ask the Secretary of State for Health, if he will take steps to ensure that the haematology department at North Tees and Hartlepool NHS Foundation Trust is retained and that vacancies at that trust are filled; and if he will make a statement.
To ask the Secretary of State for Health, if he will take steps to ensure that the haematology department at North Tees and Hartlepool NHS Foundation Trust is retained and that vacancies at that trust are filled; and if he will make a statement.
This is a matter for the National Health Service locally.
We have written to Paul Garvin, Chair of the North Tees and Hartlepool NHS Foundation Trust, informing him of the hon. Member’s enquiry. He will reply shortly and a copy of the letter will be placed in the Library.
I. Patient self-testing using the Roche CoaguChek S. 47 p. II. Patient self-management using the CoaguChek S. 28 p. III. CoaguChek XS System. 32 p. IV. Point of Care Coagulators for Monitoring Oral Anticoagulation. 35 p.
I. Patient self-testing using the Roche CoaguChek S. 47 p. II. Patient self-management using the CoaguChek S. 28 p. III. CoaguChek XS System. 32 p. IV. Point of Care Coagulators for Monitoring Oral Anticoagulation. 35 p.
To ask the Secretary of State for Health which cancer networks (a) have met and (b) are on target to meet the milestones set out in the National Institute for Health and Clinical Excellence's guidance on improving outcomes in haemato-oncology cancer, published in October 2003.
To ask the Secretary of State for Health which cancer networks (a) have met and (b) are on target to meet the milestones set out in the National Institute for Health and Clinical Excellence's guidance on improving outcomes in haemato-oncology cancer, published in October 2003.
To ask the Secretary of State for Health when his Department plans to review the national haematology guidelines; and if he will make a statement.
To ask the Secretary of State for Health when his Department plans to review the national haematology guidelines; and if he will make a statement.
To ask the Secretary of State for Northern Ireland, how much was spent on (a) haemophilia and (b) haematology drugs in the Province in each of the last five years; and what the expected spending is over the next 12 months. - Inc figures and table.
To ask the Secretary of State for Northern Ireland, how much was spent on (a) haemophilia and (b) haematology drugs in the Province in each of the last five years; and what the expected spending is over the next 12 months. - Inc figures and table.
To ask the Secretary of State for Health, what percentage of the increase in funding for cancer was allocated to haematology, with particular reference to myeloma; and what proportion of this sum was spent on staff training. - Inc figure.
To ask the Secretary of State for Health, what percentage of the increase in funding for cancer was allocated to haematology, with particular reference to myeloma; and what proportion of this sum was spent on staff training. - Inc figure.
Adjournment debate on Pembury Hospital haematology research unit
Adjournment debate on Pembury Hospital haematology research unit
To ask the Secretary of State for Health, what his policy is on the co-ordination of neonatal intensive care with the paediatric surgical sub-specialisation of (a) cleft lip and palate, (b) ophthalmology and (c) otolaryngology; what his policy is on establishing a set of national care standards for neonatal intensive...
To ask the Secretary of State for Health, what his policy is on the co-ordination of neonatal intensive care with the paediatric surgical sub-specialisation of (a) cleft lip and palate, (b) ophthalmology and (c) otolaryngology; what his policy is on establishing a set of national care standards for neonatal intensive...